Article Information
PubMed
Print ISSN
Online ISSN
History
- Received February 23, 2006
- Accepted July 25, 2006
- Published online October 19, 2006.
Article Versions
- Earlier version (August 1, 2006 - 09:31).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Lorenz M. Jost,
- Hans-Peter Gschwind,
- Tarja Jalava,
- Yongyu Wang,
- Clemens Guenther,
- Claire Souppart,
- Antje Rottmann,
- Karsten Denner,
- Felix Waldmeier,
- Gerhard Gross,
- Eric Masson and
- Dirk Laurent
- Kantonsspital Bruderholz, Oncology Department, Bruderholz, Switzerland (L.M.J.); Novartis Pharma AG, Exploratory Development, Basel, Switzerland (H.-P.G., C.S., F.W., G.G.); Schering Oy, Research & Development, Helsinki, Finland (T.J.); Schering AG, Berlin, Germany (C.G., A.R., K.D., D.L.); and Novartis Pharmaceuticals Corporation, Oncology Business Unit, Florham Park, New Jersey (E.M., Y.W.)
- Address correspondence to:
Dr. Hans-Peter Gschwind, Exploratory Development/Drug Metabolism & Pharmacokinetics, Novartis Pharma AG, Building WKL-135.2.25, CH-4002 Basel, Switzerland. E-mail: hans-peter.gschwind{at}novartis.com